Topics

Articles

East Syracuse site will serve as  a hub for company’s US biologics CDMO business

Among functions, 80,000 square-foot space will house a 'Center of Excellence'

Location will feature aseptic fill-finish technology

Among efforts, part of center’s focus revolves providing tools for product commercialization 

Facility will feature biologic manufacturing, along with late-stage research and clinical development of cancer medicines

Deal for New Jersey cell therapy site totals $44.5 million

Commercial-scale center will cost $650 million, featuring 144,000 liters of biomanufacturing capacity

Deal adds biopharma services to its capabilities

Will address biologics drug substance and drug product manufacturing services